Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

500 women test supplement for menopause relief

NCT ID NCT07117994

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 33 times

Summary

This completed trial tested a dietary supplement called Radicle Revive in 500 perimenopausal women aged 40 and older. For 6 weeks, participants took either the active supplement or a placebo, and researchers measured changes in stress, sleep, and menopause-related health issues. The goal was to see if the supplement could improve common perimenopause symptoms like fatigue and poor sleep.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FATIGUE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Radicle Science, Inc

    Del Mar, California, 92014-2605, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

dietary supplement (Radicle Revive Active Study Product 1)

What this could lead to

If it works, this could point toward a natural supplement option to ease stress, sleep problems, and other perimenopause symptoms.

What could go wrong

This is a small, completed trial with no phase designation, so results are preliminary. The supplement may work no better than placebo, and individual results can vary.

Conditions

The condition(s) this trial relates to.

Fatigue sleep disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.